参考文献/References:
[1] Gashler AL,Swaminathan S,Sukhatme VP.A novel repression module,an extensive activation domain,and a bipartite nucle-ar localiza-tion signal defined in the immediate-early transcrip-tion factor Egr-l.Mol Cell Biol,1993,13(8):4556-4571.
[2] Bickenbach KA,Veerapong J,Shao MY,et al.Resveratrol is an effec-tive inducer of CArG-driven TNF-alpha gene therapy.Cancer Gene Ther,2008,15(3):133-139.
[3] Wang WD,Li R,Chen ZT,et al.Cisplatin-controlled p53 gene ther-apy for human non-small cell lung cancer xenografts in athymic nude mice via the CArG elements.Cancer Sci,2005,96(10):706-712.
[4] Lucerna M,Pomyje J,Mechtcheriakova D,et al.Sustained expression of early growth response protein-1 blocks angiogene-sis and tumorgrowth.Cancer Res,2006,66(13):6708-6713.
[5] Parra E,Ortega A,Saenz L.Down-regulation of Egr-1 by siR-NA inhibits growth of human prostate carcinoma cell line PC-3.Oncol Rep,2009,22(6):1513-1518.
[6] Tsurushima H,Yuan X,Dillehay LE,et al.Radiation-inducible caspase-8 gene therapy for malignant brain tumors.Int J Radiat Oncol Biol Phys,2008,71(2):517-525.
[7] Tsumshima H,Yuan X,Dillehay LE,et al.Radioresponsive tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) gene therapy for malignant brain tumors.Cancer Gene Ther,2007,14(8):706-716.
[8] Weichselbaum RR,Hallahan DE,Beckett MA,et al.Gene therapy targeted by radiation preferentially radiosensitizes tumor cells.Cancer Res,1994,54(16):4266-4269.
[9] Hallahan DE,Qu S,Geng L,et al.Radiation-mediated control of drug delivery.Am J Clin Oncol,2001,24(5):473-480.
[10] Senzer N,Mani S,Rosemurgy A,et al.TNFerade biologic,an adenovector with a radietion-inducible promoter,carrying the human tumor necrosis factor alpha gene:a phase Ⅰ study in patients with solid tumors.J Clin Oncol,2004,22(4):592-601.
[11] MacGill RS,Davis TA,Macko J,et al.Local gene delivery of tumor necrosis factor alpha can impact primary tumor growth and metastases through a host-mediated response.Clin Exp Metastasis,2007,24(7):521-531.
[12] Kawashita Y,Ohtsuru A,Kaneda Y,et al.Regression of hepatocellular carcinoma in vitro and in vivo by radiosensitizing suicide gene therapy under the inducible and spatial control of radiation.Hum Gene Ther,1999,10(9):1509-1519.
[13] Hsu H,Rainov NG,Quinones A,et al.Combined radiation and cytochrome CYP4Bl/4-ipomeanol gene therapy using the EGR1 promoter.Anticancer Res,2003,23(3B):2723-2728.
[14] Scott SD,Marples B,Hendry JH,et al.A radiation-controlled molec-ular switch for use in gene therapy of cancer.Gene Ther,2000,7(13):1121-1125.
[15] Jin GH,Jin SZ,Liu Y,et al.Therapeutic effect of gene-therapy in combination with local X-irradiation in a mouse malignant melanoma model.Biochem Biophys Res Commun,2005,330(3):975-981.
[16] Greco O,Marples B,Dachs GU,et al.Novel chimeric gene promoters responsive to hypoxia and ionizing radiation.Gene Ther,2002,9(20):1403-1411.
[17] Manome Y,Kunieda T,Wen PY,et al.Transgene expression in malignant glioma using a replication-defective adenoviral vector containing the Egr-1 promoter:activation by ionizing radiation or uptake of radioactive iododeoxyuridine.Hum Gene Ther,1998,9(10):1409-1417.
[18] Kawashita Y,Ohtsuru A,Miki F,et al.Eradication of hepatocellular carcinoma xenografts by radiolabelled,lipiodolinducible gene therapy.Gene Ther,2005,12(22):1633-1639.
[19] Takahashi T,Namiki Y,Ohno T.Induction of the suicide HSV-TK gene by activation of the Egr-1 promoter with radioisotopes.Hum Gene Ther,1997,8(7):827-833.
相似文献/References:
[1]李景涛,邓垒,张文珏,等.广泛期小细胞肺癌胸部IMRT后发生放射性肺炎的危险因素分析[J].国际放射医学核医学杂志,2016,40(2):100.[doi:10.3760/cma.j.issn.1673-4114.2016.02.003]
Li Jingtao,Deng Lei,Zhang Wenjue,et al.Risk factor analysis for predicting radiation pneumonitis in extensive stage small cell lung cancer patients receiving IMRT thoracic radiotherapy[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(4):100.[doi:10.3760/cma.j.issn.1673-4114.2016.02.003]
[2]刘佳,高刚,朴春南,等.调节肿瘤放射敏感性的miRNAs研究进展[J].国际放射医学核医学杂志,2016,40(2):159.[doi:10.3760/cma.j.issn.1673-4114.2016.02.015]
Liu Jia,Gao Gang,Piao Chunnan,et al.Progress of microRNAs in regulating tumor radiation sensitivity[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(4):159.[doi:10.3760/cma.j.issn.1673-4114.2016.02.015]
[3]陈晓艳,张江虹,邵春林.STAT3与辐射敏感相关性的研究进展[J].国际放射医学核医学杂志,2016,40(3):191.[doi:10.3760/cma.j.issn.1673-4114.2016.03.007]
Chen Xiaoyan,Jianghong,Shao Chunlin.Research progresses of correlation between STAT3 and radiosensitivity[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(4):191.[doi:10.3760/cma.j.issn.1673-4114.2016.03.007]
[4]赵德云,李百龙.植物提取物防治放射性肺损伤的现状与展望[J].国际放射医学核医学杂志,2016,40(3):208.[doi:10.3760/cma.j.issn.1673-4114.2016.03.010]
Zhao Deyun,Li Bailong.Protective and therapeutic effects of plant extracts on radiation-induced lung injury:present status and future prospects[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(4):208.[doi:10.3760/cma.j.issn.1673-4114.2016.03.010]
[5]田琦,蒋宁一,郑丽.265例精细个体化131I治疗Graves甲亢的疗效观察[J].国际放射医学核医学杂志,2016,40(4):259.[doi:10.3760/cma.j.issn.1673-4114.2016.04.004]
Tian Qi,Jiang Ningyi,Zheng Li.Therapeutic effect of fine individual 131I treatment on Graves disease hyperthyroidism[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(4):259.[doi:10.3760/cma.j.issn.1673-4114.2016.04.004]
[6]邓大平,卢峰,孙洪强,等.颅脑肿瘤放射治疗时射野外器官吸收剂量体模法测量与分析[J].国际放射医学核医学杂志,2016,40(4):272.[doi:10.3760/cma.j.issn.1673-4114.2016.04.007]
Deng Daping,Lu Feng,Sun Hongqiang,et al.Test and analysis of out-of-field organ dose in intracranial tumor radiotherapy using phantom[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(4):272.[doi:10.3760/cma.j.issn.1673-4114.2016.04.007]
[7]赵舒怡,储小飞,樊赛军.血清肿瘤标志物与肿瘤放疗疗效评估的研究进展[J].国际放射医学核医学杂志,2015,39(5):427.[doi:10. 3760 / cma. j. issn. 1673-4114. 2015. 05. 018]
zhao shuyi,chu xiaofei,fan saijun..progression of study on serum tumor markers in evaluation of tumor radiotherapy[J].International Journal of Radiation Medicine and Nuclear Medicine,2015,39(4):427.[doi:10. 3760 / cma. j. issn. 1673-4114. 2015. 05. 018]
[8]赵徵鑫,翟贺争,张文艺,等.质子重离子治疗肿瘤的进展[J].国际放射医学核医学杂志,2016,40(5):384.[doi:10.3760/cma.j.issn.1673-4114.2016.05.010]
Zhao Zhixin,Zhai Hezheng,Zhang Wenyi,et al.Development of proton heavy ion in tumor therapy[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(4):384.[doi:10.3760/cma.j.issn.1673-4114.2016.05.010]
[9]段永璇,邹晓艳,段秀梅,等.数据解析在肿瘤放射治疗中的应用[J].国际放射医学核医学杂志,2015,39(6):505.[doi:10.3760/cma.j.issn.1673-4114.2015.06.015]
Duan Yongxuan,Zou Xiaoyan,Duan Xiumei,et al.Data analysis in the field of tumor radiation therapy[J].International Journal of Radiation Medicine and Nuclear Medicine,2015,39(4):505.[doi:10.3760/cma.j.issn.1673-4114.2015.06.015]
[10]贾立立,孟粹达,刘晓冬,等.头颈部肿瘤放疗中转化医学相关机制的研究进展[J].国际放射医学核医学杂志,2015,39(3):247.[doi:10.3760/cma.j.issn.1673-4114.2015.03.013]
Jia Lili,Meng Cuida,Liu Xiaodong,et al.Development in translational medicine-related mechanisms of radiotherapy for head and neck cancer[J].International Journal of Radiation Medicine and Nuclear Medicine,2015,39(4):247.[doi:10.3760/cma.j.issn.1673-4114.2015.03.013]
[11]周冲,王利利,周菊英.微小RNAs在分子放射生物学中的研究进展[J].国际放射医学核医学杂志,2009,33(2):109.[doi:10.3760/cma.j.issn.1673-4114.2009.02.014]
ZHOU Chong,WANG Li-li,ZHOU Ju-ying.Progress of microRNAs in molecular radiobiology[J].International Journal of Radiation Medicine and Nuclear Medicine,2009,33(4):109.[doi:10.3760/cma.j.issn.1673-4114.2009.02.014]
[12]刘军叶,郭鹞,郭国祯.乏氧靶向性自杀基因治疗系统增强胰腺癌放疗效果的实验研究[J].国际放射医学核医学杂志,2006,30(3):168.
LIU Jun-ye,GUO Yao,GUO Guo-zhen.Hypoxia-targeted suicidal gene therapy system enhances antitumor effects of radiotherapy on pancreatic cancer[J].International Journal of Radiation Medicine and Nuclear Medicine,2006,30(4):168.